Outdoor Activities and Myopia Development

NEI: Early Anti-VEGF Injections May Slow DR Progression

A Peek into the Diabetic Retinopathy Pipeline

Though anti-VEGF injections dominate today’s treatment landscape, novel therapies are in the works.

Ophthalmologists in the Machine: The AI Era

Experts discuss the upsides and downsides of AI and the new FDA-approved devices for diabetic eye disease.